Cancer.Net featured an expert Q&A with our Clinical Executive Director Dr. Jack West on the impact of biomarker testing for lung cancer treatment. He highlights the benefits of knowing which biomarkers a lung cancer diagnosis has because, in some cases, targeted therapies may be available to block mutations that could be driving the cancer’s growth. Furthermore, Dr. West shares about when biomarker testing is most useful, and questions for people to consider when meeting their doctor.
